Cerevel Therapeutics

YTD

ALL

Why Robinhood?

You can watch CERE and buy or sell other stocks, ETFs, and their options commission-free!

About CERE

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease.

CEO

Ronald C. Renaud, Jr., MBA

CEORonald C. Renaud, Jr., MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2018

Founded2018

Employees

—

Employees—

CERE Key Statistics

Market cap

8.18B

Market cap8.18B

Price-Earnings ratio

-16.46

Price-Earnings ratio-16.46

Dividend yield

—

Dividend yield—

Average volume

2.06M

Average volume2.06M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$44.99

52 Week high$44.99

52 Week low

$19.59

52 Week low$19.59

People also own

Based on the portfolios of people who own CERE. This list is generated using Robinhood data, and it’s not a recommendation.